MIST
Price
$2.33
Change
-$0.08 (-3.32%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
205.26M
132 days until earnings call
Intraday BUY SELL Signals
OSRH
Price
$0.49
Change
-$0.01 (-2.00%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
12.85M
Intraday BUY SELL Signals
Interact to see
Advertisement

MIST vs OSRH

Header iconMIST vs OSRH Comparison
Open Charts MIST vs OSRHBanner chart's image
Milestone Pharmaceuticals
Price$2.33
Change-$0.08 (-3.32%)
Volume$6.15K
Capitalization205.26M
OSR Holdings
Price$0.49
Change-$0.01 (-2.00%)
Volume$500
Capitalization12.85M
MIST vs OSRH Comparison Chart in %
MIST
Daily Signal:
Gain/Loss:
OSRH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MIST vs. OSRH commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIST is a Hold and OSRH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (MIST: $2.41 vs. OSRH: $0.50)
Brand notoriety: MIST and OSRH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MIST: 365% vs. OSRH: 12%
Market capitalization -- MIST: $198.44M vs. OSRH: $12.66M
MIST [@Biotechnology] is valued at $198.44M. OSRH’s [@Biotechnology] market capitalization is $12.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIST’s FA Score shows that 0 FA rating(s) are green whileOSRH’s FA Score has 1 green FA rating(s).

  • MIST’s FA Score: 0 green, 5 red.
  • OSRH’s FA Score: 1 green, 4 red.
According to our system of comparison, MIST is a better buy in the long-term than OSRH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIST’s TA Score shows that 4 TA indicator(s) are bullish while OSRH’s TA Score has 2 bullish TA indicator(s).

  • MIST’s TA Score: 4 bullish, 6 bearish.
  • OSRH’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, MIST is a better buy in the short-term than OSRH.

Price Growth

MIST (@Biotechnology) experienced а +26.18% price change this week, while OSRH (@Biotechnology) price change was -11.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

MIST is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MIST($205M) has a higher market cap than OSRH($12.8M). MIST YTD gains are higher at: 2.119 vs. OSRH (-95.660). OSRH has higher annual earnings (EBITDA): -12.05M vs. MIST (-51.72M). MIST has more cash in the bank: 43.4M vs. OSRH (1.58M). OSRH has less debt than MIST: OSRH (4.3M) vs MIST (56.4M). OSRH has higher revenues than MIST: OSRH (105K) vs MIST (0).
MISTOSRHMIST / OSRH
Capitalization205M12.8M1,602%
EBITDA-51.72M-12.05M429%
Gain YTD2.119-95.660-2%
P/E RatioN/AN/A-
Revenue0105K-
Total Cash43.4M1.58M2,740%
Total Debt56.4M4.3M1,313%
FUNDAMENTALS RATINGS
MIST: Fundamental Ratings
MIST
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MISTOSRH
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
55%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
27%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
14%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
52%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 23 days ago
67%
Declines
ODDS (%)
Bearish Trend 13 days ago
80%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
18%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MIST
Daily Signal:
Gain/Loss:
OSRH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FMFC0.690.06
+9.64%
Kandal M Venture Limited
ROL58.610.65
+1.12%
Rollins
PLMR129.501.02
+0.79%
Palomar Holdings
TXO13.33-0.05
-0.37%
TXO Partners LP
ELTX8.51-0.21
-2.41%
Elicio Therapeutics

MIST and

Correlation & Price change

A.I.dvisor tells us that MIST and AKBA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIST and AKBA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
+3.88%
AKBA - MIST
33%
Poorly correlated
-6.25%
GYRE - MIST
29%
Poorly correlated
-4.74%
PRAX - MIST
29%
Poorly correlated
-6.89%
OSRH - MIST
29%
Poorly correlated
+3.13%
KYTX - MIST
28%
Poorly correlated
+9.50%
More

OSRH and

Correlation & Price change

A.I.dvisor tells us that OSRH and MIST have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OSRH and MIST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSRH
1D Price
Change %
OSRH100%
+3.13%
MIST - OSRH
29%
Poorly correlated
+3.88%
EDSA - OSRH
23%
Poorly correlated
+0.29%
EDIT - OSRH
22%
Poorly correlated
+1.55%
LEXX - OSRH
22%
Poorly correlated
+3.47%
VERA - OSRH
21%
Poorly correlated
-2.00%
More